On Tuesday, August 29th, the Biden administration announced the first 10 drugs that Medicare will start negotiating the prices of with manufacturers as part of the Inflation Reduction Act. The Act allowed Medicare to negotiate prices for drugs to lower their costs. These negotiations with drug manufacturers will significantly lower prescription drug costs for Indian and South Asian Medicare recipients.

Heart disease is the leading cause of death for men and women of all ethnicities nationwide. However, South Asians develop coronary artery disease an average of up to 10 years earlier than the general population. This community only comprises 25% of the world population and yet makes up 60% of all cases of heart disease.